ArticleInternational journal of ophthalmology2025
Clinical profiles of thyroid eye disease with and without strabismus: a comparative study.
Article in International journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Medium-dose intravenous methylprednisolone pulse therapy for thyroid-associated orbitopathy.International journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo identify differences in clinical features between thyroid eye disease (TED) patients with and without strabismus.
methodsThis retrospective, single-center, consecutive case series study was conducted on TED patients who were determined to be surgical candidates. The patients' cohort were divided into two groups based on the presence or absence of strabismus. Demographics and complete eye examinations were recorded and compared between the TED and TED with strabismus groups.
resultsA total of 76 patients with TED were enrolled, including 58 males (76.3%) with a mean age of 52.68±10.45y. The 55 patients (male:female=2:1) were found to have TED with strabismus, while the remaining 21 patients (male:female=4:1) had TED without strabismus. There was nearly a four times greater likelihood of lid retraction being associated with TED without strabismus (OR=4.1,
conclusionStrabismus-associated TED is characterized by a lower prevalence of proptosis and lid retraction, but a higher incidence of compensatory AHP. Identifying these differences may aid in risk stratification and early intervention for TED patients, particularly those at risk for restrictive strabismus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.